What is Conceivex?
Conceivex, Inc. provides the Conception Kit, an FDA-cleared at-home system designed to support couples in their efforts to conceive. The comprehensive kit includes essential tools such as cervical caps, ovulation predictors, and pregnancy tests, offering a natural and cost-effective initial step for individuals seeking to start a family. The company targets couples experiencing fertility challenges, aiming to improve conception success rates while mitigating the emotional and financial burdens often associated with advanced fertility treatments. The Conception Kit is accessible via prescription and is covered by a significant number of insurance plans, highlighting Conceivex's commitment to broad accessibility.
How much funding has Conceivex raised?
Conceivex has raised a total of $2.6M across 2 funding rounds:
Debt
$2.5M
Debt
$12K
Debt (2015): $2.6M, investors not publicly disclosed
Debt (2021): $12K led by PPP
Key Investors in Conceivex
PPP
Public-Private Partnership
What's next for Conceivex?
The recent infusion of moderate growth capital suggests Conceivex is poised for scaling its operations and potentially expanding its product offerings or market reach. This strategic investment will likely fuel initiatives aimed at enhancing the Conception Kit's accessibility, further developing its technology, or increasing marketing efforts to reach a wider audience of couples facing fertility concerns. The company's focus on an affordable, natural, and prescription-based approach positions it favorably within the growing femtech and fertility support sector.
See full Conceivex company page
